Argent BioPharma Limited (RGTLF)
OTCMKTS · Delayed Price · Currency is USD
0.0485
0.00 (0.00%)
At close: Aug 11, 2025
Argent BioPharma Market Cap
Argent BioPharma has a market cap or net worth of $3.35 million as of August 14, 2025. Its market cap has decreased by -64.61% in one year.
Market Cap
3.35M
Enterprise Value
9.01M
Revenue
183.08K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since September 28, 2012, Argent BioPharma's market cap has increased from 3.23M to 3.35M, an increase of 3.71%. That is a compound annual growth rate of 0.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 3.33M | -41.72% |
| Dec 31, 2024 | 5.71M | -51.68% |
| Dec 29, 2023 | 11.82M | -45.80% |
| Dec 30, 2022 | 21.80M | -69.97% |
| Dec 31, 2021 | 72.60M | 110.51% |
| Dec 31, 2020 | 34.49M | 11.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 560.80M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 367.14M |
| CytoDyn | 300.75M |